Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties
1998
Biomaterials 1998 Jul ;19(14):1275-1285 | Laboratoire d'Etude des Materiaux Plastiques et des Biomateriaux (UMR CNRS 5627), Universite Claude Bernard, Villeurbanne, France
Characterization of detergent-induced barrier alterations -- effect of barrier cream on irritation
1998
J Investig Dermatol Symp Proc 1998 Aug ;3(2):121-127 | Department of Dermatology, University of Erlangen/Nurnberg, Erlangen, Germany
Use of dermal equivalent and skin equivalent models for in vitro cutaneous irritation testing of cosmetic products : Comparison with in vivo human data
1998
International journal of cosmetic science 1998 ;17 (1):5-17 | Laboratoire des Substituts Cutanes, Lyon, France
Activation of fibroblast metabolism in a dermal and skin equivalent model : a screening test for activity of peptides
1998
Biomaterials 1998 ;20 (3):159-173 | COLETICA, 32, rue Saint Jean de Dieu, Lyon, France; Laboratoire des Substituts Cutanes, CNRS URA 1341, Hopital Edouard Herriot, 3, place d'Arsonval, Lyon, France
Investigations on the regulation of secreted aspartyl proteases in a model of oral candidiasis in vivo
1998
Mycoses. 1998;41 Suppl 2:69-73. | Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Germany.
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity.
1998
Mol Microbiol. 1998 Jul;29(2):605-15. | Institute for General Botany, Applied Molecular Biology III, University of Hamburg, Germany.
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity
1998
Mol Microbiol. 1998 Jul;29(2):605-15. | Institute for General Botany, Applied Molecular Biology III, University of Hamburg, Germany.
Comparison of an in vitro skin model to normal human skin for dermatological research
1997
Microsc Res Tech 1997 ;37 (3):172-9 | Cutaneous Pharmacology and Toxicology Center, North Carolina State University, Raleigh 27606, USA.
Comparison of six different methods to assess UVA cytotoxicity on reconstructed epidermis. Relevance of a fluorimetric assay (the calcein-AM) to evaluate the photoprotective effects of alpha-tocopherol
1997
TOXICOL VITRO. Toxicology in Vitro 1997 ;11 (5):645-651 | M.S. Noel-Hudson, Laboratoire de Pharmacologie, Unite de Dermopharmacologie, Faculte de Pharmacia, 5 rue J.B. Climent, 92296 Chatenay-Malabry Cedex
Differential expression of collagens XII and XIV in human skin and in reconstructed skin
1997
J Invest Dermatol 1997 ;108 (5):737-42 | Laboratory of Experimental Organogenesis, Saint-Sacrement Hospital, Quebec, Canada.
Epidermal growth factor and temperature regulate keratinocyte differentiation
1997
Arch Dermatol Res 1997 ;289 (6):317-26 | Department of Dermatology, Leiden University Hospital, The Netherlands.
Incomplete differentiation of fetal keratinocytes in the skin equivalent leads to the default pathway of apoptosis
1997
EXP CELL RES. Experimental Cell Research 1997 ;231 (1):83-95 | A.R. Haake, Department of Dermatology, Univ. of Rochester Med./Dent. Sch., Box 697, 601 Elmwood Avenue, Rochester, NY 14642
Light and electron microscopic findings in human epidermis reconstructed in vitro upon topical application of liposomal tretinoin
1997
Acta Derm Venereol 1997 ;77 (2):122-6 | Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany.
Reconstructed skin for in vitro cutaneous pharmacotoxicology: Example of metabolic studies
1997
IN VITRO TOXICOL J MOL CELL TOXICOL. In Vitro Toxicology: Journal of Molecular and Cellular Toxicology 1997 ;10 (1):3-9 | R. Roguet, Life Sciences, L'Oreal Advanced Res. Laboratories, 1 Avenue E. Schueller, 93600 Aulnay sous Bois
A skin equivalent model for cosmetological trials: an in vitro efficacy study of a new biopeptide
1997
Skin Pharmacol 1997 ;10 (2):63-70 | Laboratoire des Substituts Cutanes, CNRS-URA 1341, Hopital Edouard-Herriot, Lyon, France.
Skin irritation testing - What are the alternatives?
1997
COMMENTS TOXICOL. Comments on Toxicology 1997 ;6 (1):87-100 | D.A. Basketter, Unilever Environm Safety Laboratory, Colworth House, Sharnbrook, Bedford MK44 1LQ EML: [email protected]
Tissue engineering and the development of Apligraf(TM), a human skin equivalent
1997
CLIN THER. Clinical Therapeutics 1997 ;19 (5):894-905 | Dr. W.H. Eaglstein, 1600 North West 10th Avenue, Miami, FL 33136
Use of dermal equivalent and skin equivalent models for identifying phototoxic compounds in vitro
1997
Photodermatol Photoimmunol Photomed 1997 ;13 (1-2):27-36 | Laboratoire des Substituts Cutanes, (CNRS-UPR 412), Hopital Edouard Herriot, Lyon, France.
Use of human skin reconstructs in the study of pigment modifiers
1997
Arch Dermatol 1997 ;133 (3):331-6 | Laboratoire de Dermatologie, Universite Victor Segalen, Bordeaux, France.
Use of in vitro dermal equivalent and skin equivalent kits for evaluating cutaneous toxicity of cosmetic products
1997
IN VITRO TOXICOL J MOL CELL TOXICOL. In Vitro Toxicology: Journal of Molecular and Cellular Toxicology 1997 ;10 (1):23-31 | O. Damour, Laboratoire de Substitute Cutanes, Pavilion 15, Hopital Edouard Herriot, 3 Place d'Arsonval, 69437 Lyon